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A B S T R A C T
Nuclear magnetic resonance relaxometry is a uniquely practical and versatile implementation of NMR
technology. Because it does not depend on chemical shift resolution, it can be performed using low-
ﬁeld compact instruments deployed in atypical settings. Early relaxometry studies of human blood were
focused on developing a diagnostic test for cancer. Those efforts were misplaced, as the measurements
were not speciﬁc to cancer. However, important lessons were learned about the factors that drive the
water longitudinal (T1) and transverse (T2) relaxation times. One key factor is the overall distribution of
proteins and lipoproteins. Plasma water T2 can detect shifts in the blood proteome resulting from in-
ﬂammation, insulin resistance and dyslipidemia. In whole blood, T2 is sensitive to hemoglobin content
and oxygenation, although the latter can be suppressed by manipulating the static and applied magnet-
ic ﬁelds. Current applications of compact NMR relaxometry include blood tests for candidiasis, hemostasis,
malaria and insulin resistance.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Nuclear magnetic resonance (NMR) encompasses a family of
diverse methods and can be divided into three broad categories:
spectroscopy, imaging and relaxometry. The early history of NMR
is rooted in spectroscopy, as chemical shift resolution has enabled
chemists and structural biologists to deduce the structures of in-
creasingly complex molecules. Since the 1980’s, the medical
community has been exploiting the spatial resolution afforded by
magnetic resonance imaging (MRI) to inform diagnosis and therapy.
Thus, the core strengths of spectroscopy and imaging are atomic
and spatial resolution, respectively. However, both approaches can
be used to study nuclear spin relaxation properties as well, yield-
ing the spin-lattice (T1) and spin-spin (T2) relaxation time constants.
The term relaxometry refers to a class of NMR experiments whose
primary emphasis is on measuring nuclear spin relaxation times,
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with the goal of characterizing the physical and dynamical prop-
erties of a sample. One of the best kept secrets in NMR is that
relaxation analyses can be performed without spectroscopy or
imaging. Although this approach sacriﬁces the power of atomic or
spatial resolution, it has three key attributes: portability, simplicity
and cost. These features enable NMR technology to penetrate new
settings, well beyond the specialized NMR laboratory or imaging
center. Benchtop or portable NMR devices, about the size of a laser
printer, are being deployed in agricultural ﬁeld sites to assess the
moisture content of seeds, or on food production lines for quality
control [1]. Compact NMR devices are being lowered deep into un-
derground oil wells for exploration and data logging [2]. And the
NMR MOUSE, a miniature one-sided NMR device, is being used for
in situ non-destructive testing of human skin, historical paintings
and other materials [3,4].
Unlike spectroscopy, where chemical shift resolution often hinges
on the use of high-ﬁeld superconducting magnets with homoge-
neous Bo ﬁelds, relaxometry can be performed using low-ﬁeld
permanent magnets with relatively inhomogeneous ﬁelds. A variety
of benchtop, portable or compact instruments have been de-
signed for this purpose. These instruments have magnetic ﬁelds of
0.1 to 1.5 Tesla, corresponding to 1H resonance frequencies of ap-
proximately 5–60MHz: one-to-two orders of magnitude lower than
the conventional NMR spectrometers used in chemistry laborato-
ries. In addition, low-ﬁeld relaxometry is forgiving with respect to
sample type. Unlike NMR spectroscopy, which depends on narrow
linewidths, relaxometry readily accommodates semi-solid or liquid
crystalline samples. It can be used with heterogeneous samples such
as seeds, crude oil, polymers, yogurt, and even whole animals for
body composition analysis.
The petroleum, agriculture and food industries were among the
ﬁrst to embrace compact NMR relaxometry and have used it to solve
a variety of practical problems in ﬁeld exploration, production and
quality control. In addition, the imaging community has used it to
evaluate contrast agents and to optimize other aspects of image con-
trast in MRI. As described below, NMR relaxometry has been
successfully implemented for several blood-based diagnostic tests,
and additional applications are being explored.
Over the last few decades, compact NMR technology has held
a back seat to the explosive developments in high-ﬁeld spectros-
copy and imaging. More recently, that order has been changing. There
is a growing recognition that a number of important problems can
be solved by NMR without the need for high-end spectroscopy or
imaging. The portability, simplicity and low cost open up exciting
new avenues and opportunities for NMR.
The purpose of this article is two-fold: (1) to review how NMR
relaxometry has, and is, being applied to the analysis of human blood
and blood components, and (2) to discuss future prospects for
compact relaxometry-based blood tests for clinical diagnosis and
population health screening. Blood is a complex, heterogeneous
mixture containing many hundreds of proteins and metabolites, as
well as lipoprotein nanoparticles, cell-derived microparticles, blood
cells, and an abundance of water. The challenge is to extract mean-
ingful health-related information from complex samples, using
simple but sound analytical approaches.
2. Methods used in compact NMR relaxometry
The primary methodological distinction of low-ﬁeld NMR
relaxometry is that data are analyzed in the time-domain, rather
than the frequency domain. In spectroscopy and imaging, the raw
time-domain signal is Fourier transformed to generate a frequency-
domain format. For spectroscopy, this calculation yields a spectrum
of peaks, each containing information about resonance frequency
(recorded as the chemical shift), as well as amplitude and phase.
Using the proper pulse sequences, relaxation times can be ex-
tracted by analyzing the decay or recovery of the amplitudes of the
frequency-domain peaks as a function of delay time.
By contrast, in relaxometry, the raw time-decay signal is ana-
lyzed without Fourier transformation. No spectra are generated, and
no chemical shifts are recorded. Rather, the relaxation times are ob-
tained by analyzing the exponential decay or recovery of the time-
domain NMR signal. Although atomic resolution is sacriﬁced, the
T1 or T2 relaxation times have some resolving power of their own
[5]. Relaxation times are sensitive to rotational and translational dif-
fusion, as well as chemical exchange processes. Thus, multi-
component or multi-phase samples may contain resolvable domains
with distinctly different T2 or T1 values. Examples include solu-
tions containing large molecules along with much smaller ones, e.g.,
proteins dissolved in an aqueous buffer. Another example is an
aqueous suspension of lipid emulsions, such as found in dairy prod-
ucts or in blood, where the dynamics of the emulsiﬁed lipid
molecules are considerably different from those in the aqueous phase.
A third example includes molecules that contain distinct mobility
domains, such as long-chain substituted hydrocarbons in oil or liquid
crystalline phases.
The methods used to acquire data in compact NMR relaxometry
are variations of the experiments used in spectroscopy and imaging.
For lucid descriptions of relaxation experiments, the reader is re-
ferred to the books by James [6], Freeman [7], and Levitt [8].
Inversion-recovery is used to acquire T1; Hahn spin-echo and Carr-
Purcell-Meiboom-Gill (CPMG) experiments are used to measure T2.
Spin-lock experiments can be used to determine the rotating-
frame relaxation time T1ρ. If quantitation of T1 or T2 is not required,
simpler experiments can be devised to compare the time-domain
free-induction decay patterns of different samples.
Another class of relaxometry experiments monitor relaxation dis-
persion, the magnetic ﬁeld dependence of relaxation times. The ﬁeld
dependence of T1, T2 and T1ρ offer insights into the mechanisms that
contribute to nuclear spin relaxation. Some of these experiments
utilize specialized hardware for fast-ﬁeld-cycling NMR [9].
Although the inversion recovery and Hahn spin echo experi-
ments have important roles in relaxometry, the CPMG experiment
is themethod of choice for analyzing and resolvingmulti-component
systems. Beyond its ability to suppress the effects of magnetic ﬁeld
inhomogeneity and other artifacts, it offers the quickest, most robust
way to record a well-sampled exponentially decaying signal with
a high signal-to-noise ratio. These requirements are critical for de-
tecting and resolving theweaker, non-water signals in plasma, serum
and blood, but also are important for obtaining accurate water re-
laxation times.
A modiﬁed CPMG pulse scheme for NMR relaxometry devel-
oped by our laboratory is shown in Fig. 1. Four features of this pulse
sequence warrant further explanation:
(1) Water suppression: The composite 180° pulse (90x180y90x) and
Δ delay was introduced prior to the CPMG scheme to par-
tially suppress the water signal and eliminate radiation
damping. Radiation damping is the additional torque on the
spin system generated by the intense water magnetization
[7], and it varies with sample size, ﬁeld strength and probe
design. It can be detected as a non-exponential artifact in the
calculated residuals of the exponential ﬁt. Using the residu-
als as a guide, the Δ delay can be tuned to eliminate radiation
damping while retaining as much water signal as possible to
enhance signal-to-noise ratio. If the residuals show oscilla-
tions or other non-random deviations from zero, the delta
delay is shortened until the residuals appear random. This ap-
proach to partial water suppression differs from high-ﬁeld
NMR spectroscopy, where the usual goal is to achieve essen-
tially complete water suppression.
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(2) Delayed acquisition: Relaxation experiments for plasma, serum
and blood samples generate several exponential decay com-
ponents, and too many components creates challenges with
multi-exponential analysis.We introduced an optional delayed
acquisition, or DA loop, to eliminate the most rapidly decay-
ing components, i.e., the 1H nuclei of large proteins or protein
assemblies. This facilitates the analysis of the slower decay-
ing components frommobile lipid and protein domains, and
from water. In most of our experiments with blood compo-
nents, the DA loop is set to eliminate the ﬁrst 19 msec of the
exponentially decaying signal.
(3) 180 pulse optimization: The 180° pulses in the CPMG loops
are phase alternated to cancel artifacts resulting from pulse
imperfections [10]. In addition, the ﬁrst 180° used for water
suppression is executed as a composite 90°x-180°y-90°x in
order to improve performance [11].
(4) Data sampling control: The adjustable DE loop determines how
frequently the spin echo intensities are acquired. Such control
becomes important if the goal is to maintain uniform sam-
plingwhile varying 2τ, the delay time between successive 180°
pulses in the CPMG scheme. It is also important for adjust-
ing data sampling for decay curves with a wide range of T2
values.
The 2τ inter-pulse delay impacts the effective CPMG ﬁeld strength
and is an important determinant of the T2 value in blood samples
[12]. Variation of CPMG ﬁeld strength can be used in relaxation dis-
persion experiments to estimate chemical exchange rates, as has
been demonstrated with protein NMR spectroscopy [13]. Also, short
2τ values are necessary to suppress contributions to T2 resulting from
the translational diffusion of molecules in an inhomogeneous ﬁeld
[14]. Inhomogeneous magnetic ﬁelds are common with the low-
ﬁeld permanent magnets used in compact relaxometers, which lack
shim coils. For a particular instrument, the inﬂuence of transla-
tional diffusion at a given temperature can be assessed by collecting
a series of CPMG experiments with increasing 2τ values. The sample
should be one where chemical exchange contributions to T2 are neg-
ligible or absent, such as pure water. Many of the early blood sample
studies described below used relatively long 2τ delays (greater than
~1ms), so it is possible that instrument-speciﬁc diffusion effects may
have contributed in part to the observed study-to-study varia-
tions in T2.
The absence of the Fourier transform in CPMG relaxometry pro-
vides two key advantages: high data sampling and quick data
acquisition. In spectroscopy, it is customary to collect an array of
10–40 spectra, each acquired with a different total CPMG decay time,
i.e., the total time allowed for partial signal decay during CPMG. In
relaxometry, the entire CPMG decay curve is acquired in just one
data set. Because of this advantage, the relaxometry curve can contain
hundreds-to-thousands of time points rather than just 10–40. The
high data sampling rate is necessary for a robust deconvolution of
multi-exponential decay curves. A highly-sampled, eight-scan CPMG
relaxometry experiment on human blood serum can be collected
in just 3–4 minutes. The short data collection time is critical for the
translation of NMR into clinical diagnostic settings, where high
sample throughput is necessary to keep testing costs down.
For mono- or bi-exponential T1 or T2 decay curves, the analysis
and extraction of relaxation times is straight forward. A bigger chal-
lenge lies in analyzing curves with three or more exponential terms.
An inverse Laplace transform can be used to extract time con-
stants and amplitudes for multi-exponential decay curves. These
algorithms are implemented in programs such as CONTIN [15] and
XPFIT [16]. The XPFIT program permits the user to choose a con-
tinuous or discrete analysis and to constrain the number of
exponential terms in the latter. While powerful and useful, caution
is warranted when performing inverse Laplace calculations. For sci-
entists used to Fourier transforms of raw NMR data, the inverse
Laplace calculation is not nearly as stable and robust [17]. If the data
is noisy, the inverse Laplace calculation may represent an ill-
posed problem [18]. The key to achieving robust inverse Laplace
analysis is to ensure that the raw CPMG decay curves have high
signal-to-noise ratios and are free of non-exponential artifacts. With
aqueous samples like blood plasma, achieving high signal-to-
noise for quantifying water T2 is not diﬃcult. However, if the goal
is to quantify the T2 values for the non-water components of blood
(proteins, lipids, etc.), extensive signal averaging is often necessary.
For quick 8- or 16-scan data acquisitions for human plasma or
serum samples using the pulse sequence in Fig. 1, we ﬁnd that stable
Fig. 1. Modiﬁed Carr-Purcell-Meiboom-Gill (CPMG) pulse sequence for measuring T2 in human blood serum or plasma using benchtop time-domain NMR relaxometry. The
key elements of the pulse sequence are discussed in the text. For a 10 mm tube, the Δ delay is tuned to 0.95*T1, which corresponds to suppression of the water to 23% of its
full intensity. For samples in a co-axial insert within a 10 mm tube, the composite 180 and delta delay are disabled. The τ delay is kept short (0.19 ms) to minimize the
possible impact of translational diffusion on T2 in an inhomogeneous Bo ﬁeld. The green loop utilizes DA = 42 to achieve delayed acquisition of the ﬁrst data point until after
the ﬁrst 19 ms of intensity decay. With DE = 5, the signal intensity of one in every six echoes was recorded during the NP loop. In contrast to conventional NMR spectros-
copy, the time points for the exponential decay curve are recorded directly during the CPMG pulse scheme, as designated by the purple arrow. The relaxation delay RD was
set to 5*T1, corresponding to ~8 sec for serum or plasma; NP = 5600, NS = 8. Phase cycles for the pulses: φ = (x)2, (−x)2, (y)2, (−y)2; ψ = x,−x. Phase cycle of the receiver: same
as φ. Total experiment time for 8 scans: 3.2 minutes. Data were recorded at 37°C using a Bruker Minispec mq20 operating at 0.47T (20MHz for 1H).
55D.P. Cistola, M.D. Robinson / Trends in Analytical Chemistry 83 (2016) 53–64
and reproducible discrete inverse Laplace ﬁts can be obtained with
three exponential terms. Three is the minimum number needed to
obtain random residuals. For longer runs with 256-to-2048 scans,
four exponential terms can be used, as the increased signal-to-
noise adds information content to the data. For concentrated samples
such as oil-phase lipids, four-term ﬁts can be used, as illustrated
below.
When using discrete inverse Laplace transforms to compare
plasma, serum or blood samples across a cohort of human sub-
jects, it is important to ﬁx the number of exponential terms to the
same number in order to obtain a valid “apples-to-apples” com-
parison. The discrete algorithm in the XPFIT program is useful for
this purpose, as it allows user control over the number of expo-
nential terms, with a maximum of four.
A sample CPMG decay curve, recorded for sample of blood serum
from a healthy human subject, is illustrated in Fig. 2A. Unlike the
conventional NMR free-induction decay, this is a pure exponential
decay curve containing no frequency oscillations. A T2 proﬁle with
four peaks, obtained by continuous inverse Laplace transforma-
tion in CONTIN, is shown in Fig. 2B. This T2 proﬁle superﬁcially
resembles a NMR spectrum, but has a different x-axis (time rather
than frequency) and a fundamentally different meaning. The large
blue peak on the right, centered at ~800msec, represents the T2 dis-
tribution for water in human serum. The area under that peak
provides the relative amplitude of that exponential component. In
addition, the proﬁle reveals three small orange peaks on the left,
corresponding to T2 distributions for protons in mobile lipid and
protein domains. This particular data set was acquired with 2048
scans in order to have suﬃcient signal-to-noise to tease out those
much smaller components. While the continuous T2 proﬁle is helpful
for visualizing the distribution of T2 values, we employ the dis-
crete algorithm in XPFIT for T2 quantiﬁcation.
Fig. 2C shows the superimposition of water peaks obtained for
serum samples from 29 asymptomatic, apparently healthy human
subjects, illustrating the signiﬁcant person-to-person variability in
serumwater T2. The source of this variability is a major focus of our
current research [19].
3. Low-ﬁeld relaxometry studies of the liquid components
of blood
Many of the water relaxometry studies of samples containing
proteins and other blood components were motivated by an inter-
est in deﬁning the factors that affect image contrast in MRI.
Relaxation times are heavily exploited in imaging, as exempliﬁed
by the schemes for recording T1- and T2-weighted images. Some low-
ﬁeld relaxometry studies have been performed using whole-body
MRI instruments, which are hardly compact. Nevertheless, those
results provide fundamental insights into the factors that drive re-
laxation times and offer a glimpse into the potential for compact
relaxometry studies of blood products.
By mass, water accounts for >80% of blood and >90% of blood
serum or plasma. Therefore, water yields the dominant 1H NMR
signal (Fig. 2B). Water molecules form hydrogen bonds with virtu-
ally every protein, lipoprotein and metabolite in the blood. Thus,
the relaxation properties of water can be used to monitor the type
and relative quantities of blood proteins and lipoproteins.
In low-ﬁeld relaxometry, it is possible to detect the lipid and
protein components directly, not via water (Fig. 2B, inset). However,
that approach requires more care in the collection of data and has
rarely been used. Therefore, most of the low-ﬁeld relaxometry studies
discussed in this reviewmonitor blood components via the spin re-
laxation of the water 1H NMR signal.
In Section 3, we begin by discussing the liquid components
of blood: fractionated serum and plasma proteins, lipids and
Fig. 2. Time-domain NMR relaxometry analysis of human blood serum. (A) Raw NMR
relaxometry data for human serum consisting of a multi-exponential CPMG decay
curve; (B) CONTIN-generated T2 proﬁle for human serum, derived from a continu-
ous inverse Laplace transform of themulti-exponential decay curve in (A). This proﬁle
is not to be confused with a conventional NMR spectrum. The T2 proﬁle reveals an
intense water peak (blue) and a few small peaks arising from directly-detected lipid
and protein components of serum (orange). (C) Expansions of the water T2 proﬁles
for individual human subjects illustrating the wide range of T2 values observed across
a cohort of 29 presumably healthy human subjects. Panel C is reproduced from ref.
[19], with permission from Wolters Kluwer Health, Inc.
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lipoproteins, followed by unfractionated whole plasma and serum.
Section 4 addresses studies of blood cells and whole blood.
3.1. Serum and plasma proteins
Proteins are highly concentrated in blood serum(6.1–8.1 g/dL) and
plasma(6.4–8.4 g/dL),withﬁbrinogenconcentrationessentiallymaking
up the difference between the two.While there are hundreds of pro-
teins in blood plasma, the tenmost abundant proteins (albumin, IgG,
transferrin, ﬁbrinogen, IgA, α2-macroglobulin, IgM, α1-antitrypsin,
C3 complement and haptoglobin) account for over 90% of the total
protein concentration, and the top two, nearly 80% [20]. Therefore, a
relatively small number of proteins and lipoproteins are the domi-
nant effectors of water T1 and T2 relaxation in serum and plasma.
An important observation is that water relaxation rates are lin-
early correlated with protein concentration, irrespective of the
protein type [21–24]. This is a consequence of several factors. Water
relaxation is modulated by Brownian molecular motions. It results
from ﬂuctuating local ﬁelds and is governed largely by the dipole-
dipole relaxationmechanism [6]. The 1H T1 and T2 values for protein-
bound water molecules in solution are inversely proportional to the
correlation time for rotational diffusion of the protein-water complex,
i.e., the time it takes for the 1H magnetic dipoles to rotate by one
radian in the static magnetic ﬁeld of the NMR instrument. In turn,
the rotational correlation time depends on temperature and vis-
cosity, as deﬁned by the generalized Stokes-Einstein-Debye equation
[25,26] which is reproduced in ref. [5]. The protein-boundwatermol-
ecules (treated as solute in the Stokes-Einstein-Debye analysis) rotate
at the much slower reorientation rate of the protein; thus, the ob-
served water T1 and T2 values in protein solutions are lower than
those of unbound water [27]. In addition, the protein-bound water
molecules undergo 1H exchange with unbound water and with the
hydrogen atoms on ionizable groups of the protein. These ex-
change processes can further decrease the observed 1H T2 value for
water [28,29]. Taken together, water relaxation times are inﬂu-
enced by the binding and exchange of water molecules on and off
protein binding sites, as well as sample viscosity.
The dominant terms contributing to water relaxation rate con-
stants are given in Equations (1) and (2). Here, R1dd,free and R2dd,free
represent the dipolar relaxation rates for free, unbound water;
R1dd,bound and R2dd,bound represent the dipole-dipole relaxation rate con-
stants for protein-
1 1 1 1 1 1T R R R Rdd free dd bound ed paramagnetic= = + +, , , (1)
1 2 2 2 2 2 2 1T R R R R R Rdd free dd bound exchange diffusion ed= = + + + +, , , , ,paramagnetic
(2)
bound water; and R2,exchange and R2,diffusion represent the contribu-
tions of chemical exchange and diffusion to R2 relaxation rates,
respectively. The remaining terms represent the electron-dipole re-
laxation resulting from paramagnetic centers.
The 1H on/off exchange rates for water (sub-nsec) are fast rela-
tive to the T1 and T2 time scales (msec-sec). Therefore, protein-
bound and unbound water yield a weighted-average T1 or T2 value.
As protein concentration increases, the fraction of bound water in-
creases and the exchange-averaged relaxation time decreases.
The contributions of individual proteins to water relaxation
can be compared using plots of water relaxation rates vs. protein
concentration. The slope of R1 or R2 vs. protein concentration is
deﬁned as the relaxivity, a measure of a protein’s effect on water
1H relaxation per unit protein concentration. Relaxivity values for
a number of human blood proteins and protein fractions are listed
in Table 1. Note that albumin, one of the lower molecular weight
proteins in blood, has the lowest relaxivity values among this
group. In general, relaxivity values increase with molecular weight.
For example, the γ-globulin fraction contains a signiﬁcant fraction
of IgM, the largest protein in blood, and IgG, which has over twice
the molecular weight of albumin. The highest relaxivity was ob-
served with transferrin, a protein that binds paramagnetic iron
and has a disproportionately large impact on water relaxation.
Except for transferrin, the R2 relaxivity values are much higher
than those for R1, indicating that R2 is much more responsive to
changes in protein concentration. That occurs, in part, because
the transverse relaxation of water in protein solutions can be
inﬂuenced by additional factors (translational diffusion and/or chem-
ical exchange) that normally do not contribute to R1. Knowing the
relaxivity values under matched conditions, one could predict the
impact of changes in the concentration of individual proteins or
protein fractions on T2 or T1.
Fig. 3 plots T2 as a function of total protein concentration for pu-
riﬁed albumin (triangles), lipoprotein-deﬁcient serum (squares), and
whole serum (circles). This plot roughly spans the range of albumin
and total protein concentration found in human serum. The ob-
served differences for these three fractions highlight the
disproportionately large impact of non-albumin proteins and lipo-
proteins on water T2 values. The apparent linearity is a consequence
of the relatively narrow range of protein concentrations exam-
ined. When the albumin plot includes protein concentrations well
below 3 g/dL, it takes on the expected hyperbolic shape of a recip-
rocal function.
Note that the curves in Fig. 3 are not relaxivity plots, as the y-axis
is T2 rather than R2. When the data are recast as R2, the plots are
linear and the slopes differ in the following order: albumin < lipo-
protein-deﬁcient serum < whole serum. This provides further
evidence that the non-albumin proteins and lipoproteins – collec-
tively termed globulins – have higher relaxivity values compared
with albumin. Thus, an increase in the globulin/albumin ratio, as
can occur in the human circulation, would be predicted to lower
serum water T2. An inverse correlation between serum or plasma
Table 1
1H T1 and T2 Water Relaxivity Values for Human Blood Components (s*g/dL)−1
Protein RT2 RT1 RT2/RT1 Bo ﬁeld Sample Temp. Ref.
Serum albumin 0.15 0.053 2.9 20 MHz 37°C [21]
0.24 0.035 6.9 42.6 MHz ambient [24]
– 0.059 – 10.7 MHz 7°C [22]
γ-globulin fraction 0.68 0.045 15 42.6 MHz ambient [24]
– 0.053 – 10.7 MHz 7°C [22]
α-globulin fraction 0.60 0.060 10 42.6 MHz ambient [24]
α + β fraction 0.46 0.052 8.9 42.6 MHz ambient [24]
– 0.101 – 10.7 MHz 7°C [22]
γ + β fraction 0.30 0.080 3.8 42.6 MHz ambient [24]
Albumin + γ-globulin 0.29 0.069 4.2 20 MHz 37°C [21]
Fibrinogen 0.50 0.03 16.7 42.6 MHz ambient [24]
Transferrin 2.6 2.4 1.1 42.6 MHz ambient [24]
Diluted whole serum 0.38 0.042 9 42.6 MHz ambient [24]
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T2 and globulin concentration or globulin/albumin ratio has been
observed in studies of human subjects [19].
Another important consideration in protein relaxometry is the
dependence of relaxation times on Bo ﬁeld strength [30]. Early re-
laxation dispersion studies of serum albumin at different
concentrations and temperatures suggested three rapidly-exchanging
pools of water: free, translationally restricted, and rotationally bound
[31]. Monitoring the temperature dependence of T1 values, ther-
modynamically structured water was observed to have different
properties in human albumin vs. γ-globulins [32]. Studies using 2H
and 17O relaxation dispersion revealed that protein water T1 relax-
ation in protein solutions is heavily inﬂuenced by a relatively small
number of tightly bound or buried water molecules that undergo
rotational motions with the protein [33,34].
An important observation for low-ﬁeld NMR is that water T2
(unlike T1) varies little with Bo, at least over the 5–60 MHz range
of ﬁeld strengths typically encountered in compact NMR instruments.
3.2. Lipids and lipoproteins
Human blood contains several classes of lipid-rich nanoparticles
termed plasma lipoproteins. The function of these particles is to
transport insoluble cholesteryl esters and triglycerides through the
circulation, and to target their lipid cargo to particular tissues and
metabolic pathways. The plasma lipoproteins are categorized by
density and consist of four main classes: low-density lipoprotein
(LDL), high-density lipoprotein (HDL), very-low density lipopro-
tein, (VLDL) and chylomicrons (CM).
The general architecture of the particles consists of an oil-
phase lipid core surrounded by a monolayer of amphiphilic
phospholipids, un-esteriﬁed cholesterol and proteins [35,36]. The
LDL and HDL particles have a cholesteryl ester-rich core, with con-
siderably less triglyceride. By contrast, VLDL and CM have a
predominately triglyceride-rich core. The physical and biological
properties of the phospholipid, cholesteryl ester and triglyceride
components are heavily inﬂuenced by their constituent fatty acids,
which vary in hydrocarbon chain length and degree of unsaturation.
Lipoprotein particles are remodeled during metabolism and
disease. For example, insulin resistance and diabetes causes LDL and
HDL to becomemore triglyceride rich, altering their uptake and clear-
ance from the blood. Moreover, the fatty acid compositions of the
particles are altered by diet and metabolism, resulting in changes
in molecular motions and lipid ﬂuidity.
Compact NMR relaxometry is well suited to track the remodel-
ing of lipoproteins in metabolism and disease. Initial work was
performed using oil-phase lipids and mixtures designed to mimic
some aspects of the lipoprotein core [5]. Fig. 4 displays the T2 pro-
ﬁles for a series of pure 18-carbon fatty acids that vary in the number
and position of double bonds. Using an inverse Laplace transform
to analyze themulti-exponential decay curves, three distinct T2 com-
ponents were resolved. These components were assigned to clusters
of protons in segments of the hydrocarbon undergoing distinct
motions. Large shifts in T2 values were seenwith increasing numbers
of cis-double bonds. The 1H T2 values for oil-phase fatty acids are
sensitive to lipid ﬂuidity which, in turn, is governed by molecular
packing [5]. This is further illustrated by the variation with hydro-
carbon chain length and double bond stereochemistry (Fig. 2 of ref.
[5]). In addition, T2 differences can be detected for lipid mixtures
that mimic the serum fatty acid compositions of individuals on diets
rich in saturated, mono-unsaturated or polyunsaturated fats (see
ﬁg. 5 of ref. [5]).
While elegant analyses have been conducted using high-
resolution NMR spectroscopy [37], there are virtually no reports using
compact relaxometry to characterize plasma lipoproteins. The data
from lipid model systems demonstrates the resolving power of T2
with respect to lipid mobility domains [5], which may be achiev-
able with lipoproteins as well. Benchtop relaxometry studies of the
lipid and protein 1H signals from lipoprotein fractions, as well as
lipoproteins in whole serum, are ongoing in our laboratory and will
be reported elsewhere.
3.3. Whole plasma and serum
Blood plasma and serum are related but distinct liquid frac-
tions of the blood. Serum is obtained after waiting for the blood to
clot in the collection tube, and then separating the ﬁbrin clot and
blood cells from the liquid supernatant by low-speed centrifuga-
tion. By contrast, plasma is obtained by centrifuging whole blood
collected using a tube that contains an anti-coagulant. Thus, serum
and plasma are not equivalent and have distinct protein composi-
tions and concentrations [20]. Plasma contains ﬁve clotting factor
proteins not present in serum, namely factors I, II, V, VIII and XIII.
All but one have low concentrations, but factor I (ﬁbrinogen) is abun-
dant, constituting approximately 4% of total plasma protein. Plasma
ﬁbrinogen levels correlate inversely with plasma water T2 relax-
ation times [23].
Water 1H relaxation times for human plasma and serum, re-
corded by different laboratories under a range of conditions, are
compiled in Table 2. The results are listed in order of increasingmag-
netic ﬁeld strength. Four main observations can be made. First, T2
values are consistently lower than those for T1. The correlation co-
eﬃcient between T1 and T2 values, measured by the same laboratory
under comparable conditions, is approximately 0.6 [38]. Com-
pared with T1, water T2 relaxation includes additional contributions
from low-frequency ﬂuctuations such as slow rotational motions,
chemical exchange and diffusion [6–8], so there is a conceptual basis
for the divergence of T1 and T2 observed with plasma samples. A
second observation is that T1 values increase with Bo magnetic ﬁeld
strength, consistent with dipole-dipole relaxation being the dom-
inant contributor to T1. By contrast, T2 shows little or no dependence
on Bo ﬁeld under these conditions. Third, the T2 values obtained with
short CPMG 2τ delays below 1ms [19,23] are noticeably higher than
those obtained with longer 2τ delays. This observation is consis-
tent with the concept that higher effective CPMG ﬁeld strength
suppresses contributions to T2 from exchange and diffusion. Fourth,
Fig. 3. Variation of water T2 values with total protein concentration for samples of
human serum albumin (▴), lipoprotein-depleted human serum (■) and whole human
serum (●). The whole serum and lipoprotein-deﬁcient serum samples were pro-
gressively diluted with phosphate-buffered saline to in order to vary total protein
concentration. Similarly, a concentrated albumin stock solution was progressively
diluted. Total protein concentrations were determined using the bicinchoninic (BCA)
assay, as implemented in a kit from the Pierce Protein Biology Division of Thermo
Fisher Scientiﬁc.
58 D.P. Cistola, M.D. Robinson / Trends in Analytical Chemistry 83 (2016) 53–64
the T1 or T2 values appear to differ in some groups of healthy in-
dividuals compared those with certain metabolic abnormalities or
diseases. This observation is discussed further in Section 3.4.
As with puriﬁed protein solutions, the relaxation rates of water
in human plasma or serum are inﬂuenced by the binding and ex-
change of water 1H with the largest and most abundant proteins
and lipoproteins. In addition, human plasma and serum contains
a number of lowmolecular weightmetabolites that can interact with
water, such as glucose and amino acids. However, water-metabolite
interactions are expected to have a negligible inﬂuence on the re-
laxation times of water, mainly because dipolar relaxation is
ineﬃcient for low molecular weight compounds. This prediction is
supported by our in vitro studies of water T2 vs. metabolite con-
centration over ranges relevant to human physiology. An exception
occurs at very high concentrations of glucose (>250 mg/dL), which
occurs in vivo only in severe, uncontrolled diabetes. Under these con-
ditions, glucose reacts non-enzymatically with protein side chains,
forming Schiff-base adducts and advanced glycation end products
that can enhance the binding of water to proteins.
Overall, water T1 and T2 values are strongly inﬂuenced by the total
serum or plasma protein concentration, as well as the relative
amounts of individual protein and lipoproteins [19,23]. High mo-
lecular weight proteins are predicted to have a disproportionately
large inﬂuence on relaxation times [39]. In addition, proteins that
have larger numbers of tightly bound waters are expected to have
a greater inﬂuence on relaxation times. Both of these factors are cap-
tured in the relaxivity value for each protein.
The observed R1 or R2 value for a given serum or plasma sample
can be estimated by summing the individual contributions of the
most abundant protein and lipoprotein components:
R obs c r c r c ri i i i( ) = + + +1 1 2 2 3 3 … (3)
Here, c1 and r1 represent the concentration and relaxivity of the
ﬁrst protein or protein class, and i = 1 or 2 for R1 or R2, respective-
ly. To ﬁrst approximation, such estimates come close to values for
whole plasma or serum [21–24]. This analysis depends on having
accurate relaxivity values for each protein and lipoprotein class, mea-
sured under an appropriately matched set of experimental
conditions.
3.4. Plasma and serum relaxometry and human disease
The early literature relating plasma or serum water 1H relax-
ation times to human disease was characterized by initial excitement
that soon led to controversy. In the 1970’s and 80’s, there was a ﬂurry
of interest in the possibility of using NMR relaxometry as a blood
test for early cancer detection [23,38–43]. The efforts in humanswere
stimulated by prior results in animals showing an increase in T1 for
tumors as compared with normal tissues [44,45] as well as a “sys-
temic effect”: an increase in the T1 for the serum of animals
developing cancer [46–48]. Subsequent studies in humans yielded
mixed results and interpretations. Several groups observed an in-
crease in plasma or serum T1 in cancer patients [38,41–43], while
others saw no signiﬁcant difference [22,23,39,40]. The relaxation
times measured in these studies are cataloged in Table 2. In the end,
it was determined that the observed changes in relaxation times
were not speciﬁc to cancer per se, but reﬂected the host’s re-
sponse to the disease. The initial enthusiasm surrounding a possible
blood test for cancer gave way to some disillusionment and skep-
ticism about using NMR relaxometry as a clinical diagnostic tool [22].
In spite of the disappointment regarding cancer, some impor-
tant lessons were learned along the way. First, the total protein
concentration and the relative distribution of proteins are among the
most important physiological factors driving plasma and serum
Fig. 4. T2 proﬁles for 18-carbon cis-unsaturated fatty acids at 37°C: Effect of double bond position and number. (A) Petroselenic acid, 18:1 cis-Δ6; (B) Oleic acid, 18:1 cis-Δ9;
(C) Vaccenic acid, 18:1 cis-Δ11; (D) Linoleic acid, 18:2 cis-Δ9,12; (E) α-Linolenic acid, 18:3 cis-Δ9,12,15. The addition of cis double bonds causes large increases in the T2 values
for resolved lipid mobility domains. This ﬁgure was reproduced from reference [5], and used by permission from the American Chemical Society.
59D.P. Cistola, M.D. Robinson / Trends in Analytical Chemistry 83 (2016) 53–64
relaxation times. As expected from the dipolar contributions to re-
laxation, larger molecular weight proteins have a disproportionate
effect, especially on lowering T2 values (Table 2 and refs. [23,39]).
The contributions from individual proteins are additive: the ob-
served relaxation times for whole plasma or serum can be estimated
by summing up the (concentration * relaxivity) terms for the main
protein fractions [21–23,39]. Endogenous paramagnetic ions in
human serum appear to have a negligible impact [21,49].
A second lesson learned was that plasma relaxation times are
inﬂuenced by viscosity as well. Protein concentration and viscos-
ity are highly correlated. After correcting for total protein
concentration, approximately 40%–60% of the variation in plasma
T2 could be explained by variations in viscosity [23]. A third lesson
was that T2 is more sensitive to protein and viscosity shifts than is
T1, when results are compared under controlled conditions and short
2τ values are used [19,23]. Much of the early efforts to correlate re-
laxation times with disease were based on T1 results only [40,42,50].
Rather than cancer, a more promising clinical application of
plasma or serum T2 measurements is in monitoring disease states
more closely associated with shifts in blood proteins and lipopro-
teins. One such shift occurs in the acute phase response to infection
or injury. The acute phase response is a component of innate im-
munity, the body’s ﬁrst line of defense against invading
microorganisms. The liver increases its secretion of some proteins
into the circulation (positive acute phase reactants) while decreas-
ing others. As albumin is a negative acute phase reactant and is
abundant in plasma and serum, the net shift in the acute phase re-
sponse is toward higher molecular weight proteins. Indeed, T2 is
signiﬁcantly lower in diseases characterized by inﬂammation or in-
fection (Table 2 and refs. [23]). Though possible, it is impractical in
the routine evaluation of a clinic patient to measure a panel of in-
dividual proteins, chemokines and cytokines in order to monitor the
acute phase response. Unlike biomarker panels, the water T2 values
provide a high-level view of shifts in the blood proteome in just one
measurement. No existing diagnostic or screening test provides such
a perspective on human physiology or pathology.
A more subtle form of inﬂammation occurs with the early met-
abolic abnormalities that precede type 2 diabetes [51,52]. Since the
Table 2
Water 1H Relaxation Times for Human Blood Plasma and Serum
Sample T1 (msec) T2 (msec) Exp. Conditionsa Physiological Conditions Ref.
Plasma 1250 ± 10 357 ± 5 8.5 MHz, 22°C 2 healthy subjects, pooledb [80]
Plasma 1410 ± 80c – 19.8 MHz, 33°C 20 healthy subjectsb [42]
Plasma 1560 ± 170c – 19.8 MHz, 33°C 18 blood cancer patientsb [42]
Plasma 1765 ± 63d 761 ± 54e 20.0 MHz, 37°C 19–23 fasting, healthy subjectsf [19]
Plasma 1440 490 20.0 MHz, 37°C 1 healthy subjectb [21]
Plasma 1481 ± 50g 565 ± 35g 20.0 MHz, 25°C 30 healthy subjectsb [38]
Plasma 1429 ± 102g 476 ± 91g 20.0 MHz, 25°C 6 leukemia patientsb [38]
Plasma 1563 ± 95g 595 ± 57g 20.0 MHz, 25°C 27 cancer patientsb [38]
Plasma 1460 ± 81g 526 ± 55g 20.0 MHz, 25°C 120 “other” diseasesb [38]
Plasma 1418 ± 60 689 ± 45 20.0 MHz, 20°C 28 healthy subjectsh [23]
Plasma 1414 ± 60 627 ± 86 20.0 MHz, 20°C 27 patients with lung diseasesi [23]
Plasma 1397 ± 50 589 ± 81 20.0 MHz, 20°C 22 patients with lung infectionsj [23]
Plasma 1402 ± 60 593 ± 74 20.0 MHz, 20°C 50 patients with lung cancers [23]
Plasma 1417 ± 90 592 ± 85 20.0 MHz, 20°C 15 patients w/lung metastases [23]
Plasma 1499 ± 7 530 ± 2 20.0 MHz, 40°C not speciﬁed [81]
Plasma 1260 ± 60 – 24.0 MHz, 22°C healthy, unspeciﬁed number [40]
Plasma 1105 ± 100 – 24.0 MHz, 22°C leukemia, unspeciﬁed number [40]
Plasma 1280 ± 70 – 24.0 MHz, 22°C cervical cancer, unspeciﬁed no. [40]
Plasma 1780 ± 20 – 35.0 MHz, 45°C healthy, unspeciﬁed numberk [50]
Plasma 1700 ± 60 – 35.0 MHz, 45°C anemia, unspeciﬁed numberk [50]
Plasma 1970 ± 480 – 35.0 MHz, 45°C leukocytosis, unspeciﬁedk [50]
Plasma 2400 ± 120 – 35.0 MHz, 45°C 2nd/3rd deg burns, unspeciﬁedk [50]
Plasma 2000 ± 10 400 ± 10 42.6 MHz, 22°C 2 healthy subjects, pooled [80]
Plasma 2041 ± 173 500 ± 50 63.9 MHz, 37°C not speciﬁed [66]
Plasma ~1200l – 14.9 MHz, 20°C not speciﬁed [59]
Plasma ~1500l – 30.2 MHz, 20°C not speciﬁed [59]
Plasma ~1700l – 40.0 MHz, 20°C not speciﬁed [59]
Plasma ~1700l – 59.6 MHz, 20°C not speciﬁed [59]
Serum 1735 ± 69m 812 ± 51n 20.0 MHz, 37°C 23 healthy subjects, 12-h faste [19]
Serum 906 ± 50 – 10.7 MHz, 7°C 30 healthy subjects [22]
Serum – 742 ± 67 20.0 MHz, 20°C 8 healthy subjects [23]
Serum 1230 ± 170 – 24.0 MHz, 22°C healthy, unspeciﬁed number [40]
Serum 1170 ± 100 – 24.0 MHz, 22°C leukemia (remission), unspeciﬁed [40]
Serum 1230 ± 90 – 24.0 MHz, 22°C cervical cancer, unspeciﬁed no. [40]
Serum 1260 ± 80 – 24.0 MHz, 22°C breast cancer, unspeciﬁed no. [40]
a A Bo ﬁeld strength of 1.0 Tesla corresponds to a 1H resonance frequency of 42.58 MHz.
b Fasting status not speciﬁed.
c Mean ± S.D. for subject population; P < 0.001 for healthy vs. blood cancer patients.
d Mean ± S.D. for 19 subjects following a 12-hour overnight fast; healthy as deﬁned in footnote f.
e Mean ± S.D. for 23 subjects following a 12-hour overnight fast; healthy as deﬁned in footnote f.
f This healthy cohort excluded individuals with a documented diagnosis of diabetes or a current HbA1c level ≥6.5, those with a recent infection or injury or a hs-CRP level
>10, and those with insulin resistance (fasting insulin > 12).
g Mean ± S.D. for subject population.
h Subjects were non-fasting.
i Lung diseases: chronic bronchitis, asthma, sarcoidosis, emphysema and pleural effusion.
j Lung infections: tuberculosis and pneumonia.
k Article in Russian; data extracted from English abstract.
l Data estimated from graph.
m Mean ± S.D. for 18 healthy subjects, as deﬁned in footnote f.
n Mean ± S.D. for 22 healthy subjects, as deﬁned in footnote f.
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1980’s, the prevalence of diabetes has been skyrocketing and has
become amajor threat to the health andwell being of societies world
wide [53]. Conventional measures for screening and prevention occur
too late, as glucose or hemoglobin A1c levels do not become abnor-
mal until over half of pancreatic insulin secretory capacity has been
irreversibly lost [54]. Thus, there is a need for practical methods that
detect diabetes and prediabetes risk at an earlier stage. Prelimi-
nary results indicate that plasma T2 is sensitive to the early insulin
resistance and metabolic inﬂammation that precede prediabetes,
metabolic syndrome and overt diabetes [19]. This is an active area
of investigation by our laboratory, and additional results are
forthcoming.
Another recent and exciting application of compact NMR
relaxometry is in the rapid diagnosis of infectious diseases such as
Candidiasis. By exploiting magnetic nanoparticles coupled with spe-
ciﬁc antibodies, low levels of infectious agents can be detected using
benchtop T2 measurements [55,56]. Related technology is being de-
veloped for the clinical evaluation of hemostasis, namely disorders
of clotting and bleeding [57]. These new applications of compact
NMR relaxometry are the focus of another article in this issue au-
thored by Thomas J. Lowery.
4. Low-ﬁeld relaxometry of whole blood and blood cells
4.1. Factors affecting relaxation times in whole blood and blood cells
In whole blood, water exists in at least two distinct compart-
ments: intracellular and plasma. The red blood cells outnumber
white blood cells by a factor of 1000 and platelets, by a factor of
ten. Moreover, red cells have ﬁve times the diameter and consid-
erably more volume than platelets. Therefore, the intracellular water
compartment for whole blood is dominated by the hemoglobin-
rich environment inside of red blood cells. The intracellular
hemoglobin concentration, clinically measured as the mean cor-
puscular hemoglobin concentration, is 32–36 g/dL: 4–5 times the
total protein concentration in plasma. From protein binding and vis-
cosity considerations alone, it follows that the water T1 and T2 values
for the intracellular compartment should be signiﬁcantly lower than
those for plasma. Indeed, the reported water relaxation times for
whole blood are lower than those for plasma. For example, the water
T1 values at 20 MHz and 37°C are approximately 900–1100 ms for
whole blood as compared with 1400–1500 ms for plasma. Like-
wise, the T2 values are ~300–500 ms lower in whole blood as
compared with plasma (Tables 2 and 3).
Another consequence of the two distinct compartments is the
asymmetric distribution of paramagnetic heme iron. Oxygenated
hemoglobin, abundant in the red blood cells of arterial blood, is dia-
magnetic. However, the deoxygenated forms abundant in venous
blood are paramagnetic. This paramagnetism results in a magnet-
ic susceptibility difference between the blood cell and plasma
compartments, generating local ﬁeld gradients that dephase water
coherence as it diffuses through those gradients. Thus, 1H water T2
decreases as the fraction of deoxy-hemoglobin increases. This phe-
nomenon was ﬁrst described by Thulborn and colleagues in 1982
[58] and has been the focus of intensive study since then [59–68].
Moreover, the paramagnetic deoxy-hemoglobin effect on T2 has been
exploited by Ogawa and colleagues to achieve blood oxygen-level
dependent (BOLD) contrast in MRI [69]. The BOLD technique has
become the mainstay of functional MRI, which revolutionized the
ﬁeld of brain activity mapping [70,71]. An interesting personal and
historical account of these discoveries was published by Thulborn
in 2012 [72].
The deoxy-hemoglobin gradient diffusion phenomenon in whole
blood affects T2 but not T1, as diffusion is not a relaxation mecha-
nism for T1. The magnitude of the effect increases with (Bo)2, with
a quadratic dependence of T2 on the fraction of deoxygenated he-
moglobin in blood [58,66,68]. The effect can be suppressed by
shortening the 2τ delay between successive 180° pulses in the CPMG
scheme (Table 3 and refs. [58,59,66,68]). It becomes insigniﬁcant
at Bo ﬁelds below ~1 T or 43 MHz for 1H when 2τ is less than a few
msec. Moreover, the effect depends on deoxy-hemoglobin being se-
questered in an intracellular compartment and can be eliminated
by lysing the red blood cells (Table 3 and refs. [58,59]).
A related, but distinct paramagnetic phenomenon affects both
T1 and T2 in whole blood. The met-hemoglobin form of deoxy-
hemoglobin contains a Fe(III) center, which permits a close proximity
of water in the ﬁrst hydration shell, leading to eﬃcient electron-
nucleus dipolar relaxation [58,61]. Both T1 and T2 are lowered, but
the effect may be more pronounced in T1 as it represents a larger
percent contribution to the relaxation mechanism. Unlike the
Table 3
Water 1H Relaxation Times for Human Blood Cells and Whole Blood
Sample T1 (msec) T2 (msec) Exp. Conditions Physiological Conditions Ref.
Blood cells 590 ± 60a – 19.8 MHz, 37°C 20 healthy subjects [42]
Blood cells 720 ± 120a – 19.8 MHz, 37°C 19 blood cancer subjects [42]
Cells (lysed) ~1100b ~230b 59.6 MHz, 20°Cc HbO2 = 100% [37]
Cells (intact) ~1200b ~210b 59.6 MHz, 20°Cd HbO2 = 100% [37]
Cells (lysed) ~600b ~230b 59.6 MHz, 20°Cc HbO2 = 0% [37]
Cells (intact) ~1200b ~140b 59.6 MHz, 20°Cd HbO2 = 0% [37]
Cells (intact) ~1200b ~60b 59.6 MHz, 20°Ce HbO2 = 0% [37]
Blood cells 879 – 60 MHz, 20°C 6 healthy, pooled [68]
Whole blood FFC/Variable, Bryant [38]
Whole blood 900 ± 90a – 19.8 MHz, 33°C 20 healthy subjects [49]
Whole blood 1100 ± 160a – 19.8 MHz, 33°C 35 blood cancer subjects [49]
Whole blood 1040 265 20 MHz, 37°C 1 healthy subject [21]
Whole blood 1020–1124 167–200 63.9 MHz, 22°C 4 healthy subjects [45]
Whole blood – 250 63.9 MHz, 22°C 5 healthy; HbO2 = 96% [40]
Whole blood – 30 63.9 MHz, 22°C 5 healthy; HbO2 = 30% [40]
Whole blood 1434 ± 48 181 ± 23 63.9 MHz, 23°C 9 healthy subjects [54]
Whole blood 1429 ± 20 ~170 63.9 MHz, 37°C not speciﬁed; HCT ~ 0.4 [43]
Whole blood 1695 ± 29 ~220 63.9 MHz, 37°C not speciﬁed; HCT ~ 0.3 [43]
Whole blood 1250 ± 156 227 ± 10 63.9 MHz, 37°C not speciﬁed [66]
a Mean ± S.D. for subject population; P < 0.001 for healthy vs. blood cancer patients.
b Data estimated from graph.
c Delay between 180 pulses in CPMG (2τ) was varied from 2 to 32 ms.
d Delay between 180 pulses in CPMG, 2τ = 2 ms.
e Delay between 180 pulses in CPMG, 2τ = 32 ms.
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paramagnetic gradient diffusion phenomenon, this electron-
nucleus dipolar relaxation effect does not depend on a sequestered
intracellular compartment and shows the most pronounced low-
ering of water T1 when the cells are lysed (Table 3).
The water relaxation times for whole blood have been ana-
lyzed and reported as single exponentials in all studies. Koivula et al.
argued that the mono-exponential behavior was a consequence of
the fast exchange of water on the T1 time scale [42]. On ﬁrst thought,
this seems counterintuitive given that distinct intracellular and ex-
tracellular water compartments are separated by a cell membrane
that is only selectively permeable to water. However, fast ex-
change is deﬁned in relative terms. The T1 time scale for whole blood
can be estimated, in this case, by the difference in water relax-
ation times for isolated plasma and blood cells, approximately 600–
800 msec (Table 3). The reported lifetime for the transmembrane
exchange of water across the red blood cell membrane is much
shorter, approximately 10 ms [73]. Moreover, T1 values for whole
blood samples diluted with their own plasma are linearly corre-
lated with hemoglobin content, providing further evidence for the
“fast” exchange of water across the red blood cell membrane [74].
Another factor to consider in the relaxation time analysis of whole
blood is the spontaneous settling of blood cells in the NMR tube,
which generates a cell pellet and plasma supernatant [66]. This
process takes just a few minutes [63], well within the time often
employed for pre-acquisition temperature equilibration and instru-
ment calibration. Some investigators have devised special mixing
tubes or ﬂow perfusion systems to prevent cell settling and tomimic
in vivo conditions [12,63,64,66,68]. However, other reports did not
specify protocols for keeping blood samples mixed during analy-
sis [58–60,62,75,76]. Sample settling could generate instrument-
dependent artifacts that depend on sample geometry and rf coil
design, with variation in the relative amounts of cell pellet and
plasma supernatant exposed to the active range the transceiver coil.
On the other hand, the fast exchange of water between compart-
ments may attenuate or eliminate some of these artifacts. In any
case, it is important to consider how sample settling may impact
the data acquisition, analysis and interpretation.
The water T1 relaxation times for whole blood and blood cells
show a signiﬁcant dependence on the Bo magnetic ﬁeld strength
[12,59,60]. For whole blood, T1 values increase from approximate-
ly 1000 ms at 20 MHz, to 1400–1700 ms at 63.9 MHz; a similar
increase is observed with isolated blood cells (Table 3). This trend
is consistent with dipolar relaxation resulting from the rotational
tumbling of watermolecules, in rapid exchange between the protein-
bound and unbound states. Dipolar relaxation becomes more
eﬃcient, and T1 becomes shorter, as the rotational correlation rate
approaches the Larmor frequency.
By contrast, the T2 values for human blood do not show this Bo
ﬁeld dependence. As discussed above, additional exchange and dif-
fusion effects are seen most vividly in deoxygenated blood or blood
cell samples. The shortest T2 values are observed in deoxygenated
samples collected with long 2τ values at higher Bo ﬁelds (Table 3
and refs. [59,60,67]).
Other factors, such as temperature, pH [38] and hematocrit
[12,66] affect the T1 and T2 values of whole blood. Precautions to
control sample pH by minimizing the release of CO2 from the in-
trinsic bicarbonate buffer system have been discussed [38].
4.2. Blood relaxometry and human disease
Like plasma and serum, whole blood relaxation times are strongly
inﬂuenced by protein content [42]. So it follows that blood T1 and
T2 values may be potential biomarkers for changes in the total con-
centration and/or relative distribution of blood proteins. Hemoglobin
is, by far, the most abundant single protein in whole blood,
representing approximately two-thirds of the total blood protein
concentration. Hemoglobin levels correlate strongly with red blood
cell count and hematocrit, the volume percent of blood taken up
by cells. Indeed, T2 values are sensitive to hemoglobin and hema-
tocrit [12,42,66,77]. So it is conceivable that T1 and/or T2 values could
be used as markers for anemia.
Anemia is a low blood cell count, or low hemoglobin level, re-
sulting from three main causes: low production, increased
degradation, or blood loss. Low production can occur in aplastic
anemia, cancer, lymphomas, iron deﬁciency, hypothyroidism and
chronic kidney disease. Anemia was the likely underlying cause of
the apparent association between increased blood T1 and cancer ob-
served in some studies [42,77]. Increased degradation can occur with
splenomegaly, porphyria, thalassemia, vasculitis, and hemolysis.
Blood loss can occur fromwounds, gastro-intestinal, urinary or men-
strual bleeding, or frequent blood donation. Anemia is routinely
identiﬁed and evaluated using a complete blood count (CBC) [78].
If red cell abnormalities can be assessed with a routine CBC, then
what added value could NMR relaxation time measurements bring
to the clinical screening of anemia? The answer lies in the advan-
tages of compact NMR relaxometry: portability, simplicity, cost. It
is conceivable that portable NMR devices could be used to measure
hematocrit and other blood cell abnormalities non-invasively. In real-
world primary care or community settings, the feasibility of
deploying new tests for population screening or front-line diagno-
sis often hinges on practical considerations like these.
Although red blood cells are the dominant cell type in whole
blood, early studies by Ekstrand et al. compared the T1 values for
white blood cells (leukocytes) in normal individuals with those for
individuals with various disease states [40]. The leukocyte T1 values
were higher in individuals with active leukemia, as well as in non-
leukemic individuals who have elevated white blood cell counts or
leukocytosis. While the clinical signiﬁcance of this ﬁnding was not
determined at that time, it is conceivable that the elevated T1 values
in leukocytosis are a characteristic of activated neutrophils, which
function as a ﬁrst line of defense against pathogens.
An exciting new application of compact NMR relaxometry to
human blood pertains to a quick and label-free diagnosis of malaria
[79]. The Plasmodium parasites that infect red blood cells metab-
olize large amounts of hemoglobin and generate paramagnetic
hemozoin crystallites. The resulting magnetic susceptibility differ-
ences lead to large changes in the water T2 values of red blood cells.
The compact NMR device designed for this work is illustrated in
Fig. 5a. The changes in R2 during repeated 48-hour life cycles of the
malaria parasite are plotted in Fig. 5b [79].
5. Conclusions and future prospects
As cataloged in this review, a sizeable number of low-ﬁeld and
compact relaxometry studies have been carried out to deﬁne the
basis for water relaxation in puriﬁed blood proteins, whole plasma
and serum, fractionated blood cells and whole blood. These results
have been steadily translated into improvements in magnetic res-
onance imaging that have dramatically enhanced image quality and
diagnostic capabilities. Several applications of compact NMR
relaxometry have been successfully translated into blood-based di-
agnostic tests for Candidiasis, malaria, and hemostasis, which signals
that compact NMR relaxometry has begun to reach its stride in clin-
ical chemistry and medicine.
Because water T2 can monitor the net effect of shifts in the dis-
tribution of many proteins in the blood with just one measurement,
it could be characterized as a method for inverse proteomics. Protein
shifts of this type occur with inﬂammation – both the acute phase
response to overt infection or injury, as well as the more subtle in-
ﬂammation that may occur with nutrient imbalance and insulin
resistance, an early predictor of prediabetes and diabetes. A
signiﬁcant opportunity lies in applying water T2 to detect subtle
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forms of inﬂammation that are not detected by conventional diag-
nostic tests. Compact NMR relaxometry is suﬃciently portable,
simple and cost-effective to be translated into such applications.
The ultimate goal is to develop simple tests that require no blood.
As water NMR signals from blood can be measured from outside
the body, one can envision a compact NMR device designed to
monitor human physiology.
Beyond medical and diagnostic applications, compact NMR
relaxometry has untapped potential as an analytical tool. Much of
the relaxometry performed to date has utilized mono-exponential
analysis and has not exploited the intrinsic resolving power of T2.
For years, academic laboratories have focused on the use of mid-
and high-ﬁeld NMR spectroscopy to achieve resolution and address
chemical problems. However, some problems or samples may lend
themselves to compact relaxometry. Because of its portability, sim-
plicity and low cost, compact NMR relaxometry should be appealing
to wide range of chemists looking for a relatively simple and ver-
satile analytical tool.
Fig. 5. Relaxometry-based method for the rapid detection of malaria parasite-infected red blood cells in whole blood, from reference [79]. The parasite is detected by its
production of hemozoin, which creates magnetic susceptibility differences and T2 changes for red blood cells. (a) Schematic illustration of the compact NMR relaxometry
system, which consists of a portable permanent magnet that provides a strong polarizing magnetic ﬁeld and a home-built radiofrequency (RF) detection probe. The bio-
sensor is connected to an RF unit, which acts as a transmitter and receiver of the RF signal. A micro centrifuge is used to separate the plasma from the RBC- and iRBC-
containing pellet inside a microcapillary tube. Themicrocapillary tube is then slotted into the RF detection probe. The RF circuitry (right) of the detection probe (50Ω impedance)
was tuned to the resonance frequency for protons (21.65 MHz) using variable capacitance at Cm = 40 pF and Ct = 800 pF. L, inductance; R, resistance of the coil; C, capaci-
tance of the circuit. (b) P. falciparum (malaria parasite) infection and the R2 responses as measured by the NMR relaxometry system. The 48-h life cycle of P. falciparum inside
red blood cells is such that the hemozoin pigment becomes more prominent as the cell cycle proceeds into the later stages. This R2 increases as the cycle progresses, and
the cultures are synchronized every 48 hours. The box plots show the lower quartile, median and upper quartile of their respective sample distributions. The control reading
(gray boxplots) is denoted as C1 to C8 for its respective days. An 2τ inter-echo time of 200 μs, consisting of 2000 echoes, a total of 24 scans, was used. 10 samplings were
taken per time point in every 24 h throughout the experiment. R2 index for post-infection cycle 1 was signiﬁcantly higher than healthy baseline (P < 0.0002), determined by
two-tailed Student’s t-test. The ﬁgures and legends were adapted from reference [79] and used by permission from the Nature Publishing Group.
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